Treatment
Glecaprevir/pibrentasvir clinical trials
We’re tracking 4 recruiting studies that include Glecaprevir/pibrentasvir, each written for real people, not researchers, below.
Recruiting studies
- NCT07040319RecruitingPhase 1/Phase 2
Hepatitis C treatment study for pregnant women
This study tests a medicine called glecaprevir/pibrentasvir for pregnant women with hepatitis C, with or without HIV. It aims to see how the medicine works in the body and if it is safe during pregnancy.
Los Angeles, CaliforniaAges 16–45 - NCT05637879RecruitingPhase 2/Phase 3
Glecaprevir for PTSD symptoms in Veterans
This Phase 2/3 study tests whether glecaprevir/pibrentasvir can reduce post-traumatic stress disorder (PTSD) symptoms. It may help Veterans whose PTSD is still affecting daily life, alongside any allowed standard care.
White River Junction, VermontAges 19–70 - NCT03855917RecruitingPhase 4
Short 4-week hepatitis C treatment for early liver disease
This trial tests whether a very short 4-week course of two hepatitis C drugs (sofosbuvir and glecaprevir-pibrentasvir) can cure hepatitis C in people with early-stage liver disease. The goal is to see if a shorter treatment works as well as longer ones.
Darlinghurst, New South WalesAges 18 years+ - NCT07419347Recruiting
Glecaprevir/Pibrentasvir safety in real-world use
This study watches how safe and well-tolerated the 8-week treatment with glecaprevir/pibrentasvir is for people with hepatitis C who are taking other prescription or illicit drugs. It helps doctors learn more about using this medicine in everyday life.
Vancouver, British ColumbiaAges 18 years+
What Glecaprevir/pibrentasvir is being studied for
Conditions with recruiting Glecaprevir/pibrentasvir studies.
Common questions
- Are there clinical trials studying Glecaprevir/pibrentasvir?
- Yes. Clin2 currently lists 4 recruiting studies that include Glecaprevir/pibrentasvir, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Glecaprevir/pibrentasvir trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Glecaprevir/pibrentasvir an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Glecaprevir/pibrentasvir or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.